1 方源扬, 刘国强, 黄显聪, 等. 景东县2004-2013年肺结核防治的卫生经济学分析[J/CD]. 中华肺部疾病杂志(电子版), 2016, 9(1): 36-40.
2 任成山, 林 辉, 杨仕明. 结核病的流行特征与耐多药的窘迫及其策略[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 269-274.
3 Magee MJ, Foote M, Maggio DM, et al. Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012[J]. Ann Epidemiol, 2014, 24(5): 369-375.
4 Shen TC, Lin CL, Wei CC, et al. Increased risk of tuberculosis in patients with type 1 diabetes mellitus[J]. Medicine, 2014, 93(16): 96-101.
5 Mi F, Jiang G, Du J, et al. Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China[J]. Global Health Action, 2014, 7(1): 24022-24029.
6 Kumar AK, Chandrasekaran V, Kannan T, et al. Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.[J]. Eur J Clin Pharmacol, 2016, 73(1): 1-6.
7 孔忠顺, 黄麦玲, 刘荣梅, 等. 糖尿病合并初治肺结核患者临床特点[J]. 中国糖尿病杂志, 2014, 6(5): 329-331.
8 米佳丽, 尹怀文, 张 兴. 2型糖尿病患者肺结核的临床特点分析[J]. 中华医院感染学杂志, 2014, 24(8): 1940-1942.
9 Lacourse SM, Chester FM, Preidis G, et al. Use of Xpert for The diagnosis of pulmonary tuberculosis in severely malnourished hospitalized malawian children[J]. Pediatr Infect Dis J, 2014, 33(11): 1200-1202.
10 Di L, Li Y. The risk factor of false-negative and false-positive for T-SPOT.TB in active tuberculosis[J]. J Clin Lab Anal, 2017, 31(2): e22273-e22273.
11 Seo KW, Ahn JJ, Ra SW, et al. Persistently Retained Interferon-Gamma Responsiveness in Individuals with a History of Pulmonary Tuberculosis[J]. Tohoku J Exp Med, 2014, 233(2): 123-128.
12 中华医学会结核病学分会. 肺结核诊断和治疗指南[J]. 中华结核和呼吸杂志, 2001, 20(2): 70-74.
13 美国糖尿病协会. 美国糖尿病协会糖尿病完全指南[M]. 北京: 北京科学技术出版社, 2014: 29-33.
14 Kumar NP, Babu S. Influence of diabetes mellitus on the immunity to human tuberculosis[J]. Immunology, 2017, 152(1): 13-24.
15 Da Costa JC, Oliveira O, Baa L, et al. Prevalence and factors associated with diabetes mellitus among tuberculosis patients: A nationwide cohort[J]. Eur Respir J, 2016, 48(1): ERJ-00254-2016.
16 Denkinger CM, Schumacher SG, Boehme CC, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis[J]. Eur Respir J, 2014, 44(2): 435-446.
17 Bojang AL, Mendy FS, Tientcheu LD, et al. Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of pulmonary tuberculosis in The Gambia[J]. J Infect Chemother, 2015, 72(3): 332-337.
18 Cai R, Chen J, Guan L, et al. Relationship between T-SPOT.TB responses and numbers of circulating CD4+ T-cells in HIV infected patients with active tuberculosis[J]. Biosci Trends, 2014, 8(3): 163-168.
19 Arenas M, Hidalgo-Tenorio C, Jimenez-Gamiz P, et al. Diagnosis of Latent Tuberculosis in Patients with Systemic Lupus Erythematosus: T.SPOT.TB versus Tuberculin Skin Test[J]. Biomed Res Int, 2014, 2: 1-8.
20 管立学, 朱 芸, 盖林林, 等. 免疫性疾病患者T-SPOT.TB筛查结果及影响因素[J]. 山东大学学报(医学版), 2016, 54(6): 82-86.
21 刘佳庆, 张丽霞, 秦中华, 等. Xpert MTB/RIF和T-SPOT.TB对涂阴肺结核诊断价值的评估[J]. 临床检验杂志, 2016, 34(10): 755-757.
22 石学萍, 王 晶, 王 鑫, 等. 结核分枝杆菌感染T细胞斑点试验在疑诊肺结核患者中的临床应用[J]. 解放军医学杂志, 2017, 42(11): 70-74.
23 蔺景双, 蔺 晨, 郝兴亮, 等. 结核感染T细胞斑点试验诊断肺结核的临床应用[J]. 山东医药, 2016, 56(48): 99-101.
24 Akhirunnesa M, Sultana RR, Mostafa KSM, et al. Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial[J]. PLOS One, 2015, 10(9): 1-25.
25 范乐平, 郭慕新, 张 玥, 等. 血清25羟维生素D3与糖尿病视网膜病变的相关性研究[J]. 营养学报, 2017, 39(2): 139-143.
26 李文和, 张丽娟, 胡译方, 等. 2型糖尿病患者血清25羟基维生素D与糖尿病肾脏疾病的相关性研究[J]. 中国糖尿病杂志, 2018, 26(5): 402-406.
27 石 洁, 朱岩昆, 郑丹薇, 等. 维生素D受体基因多态性与环境因素交互作用对河南省结核病发病影响[J]. 现代预防医学, 2017, 17(11): 174-178.
28 Sinha S, Gupta K, Mandal D, et al. Serum and Bronchoalveolar Lavage Fluid 25(OH)Vitamin D3 Levels in HIV-1 and Tuberculosis: A Cross-Sectional Study from a Tertiary Care Center in North India.[J]. Curr Hiv Res, 2018, 16(2): 167-173.
29 罗光燕, 杨小琼, 张 芸, 等. 25羟维生素D3与抗菌肽在反复上呼吸道感染中的作用研究及相关性分析[J]. 重庆医学, 2016, 45(29): 4053-4055.
30 喻 文, 罗红敏. 维生素D3对脓毒症患者维生素D和抗菌肽水平的影响:一项随机安慰剂对照试验[J]. 中华危重病急救医学, 2016, 28(2): 98-98.
31 Afsal K, Harishankar M, Banurekha VV, et al. Effect of 1,25-dihydroxy vitamin D3 on cathelicidin expression in patients with and without cavitary tuberculosis[J]. Tuberculosis, 2014, 94(6): 599-605.
32 战云飞. 维生素D、LL-37和细胞因子在糖尿病合并肺结核患者的水平研究[D]. 山东大学, 2014: 12-23.